InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: Bluenose49 post# 42284

Thursday, 11/30/2017 9:20:14 PM

Thursday, November 30, 2017 9:20:14 PM

Post# of 48316
When Oncosec uplisted to the Nasdaq index on the prospects of the first combo study with Merck the share price was $5.50 with a market cap between 150 to 200 million, I forget exactly. Good Pisces trial results and the market reaction would be obviously very good, the stock could overshoot to the upside in a parabolic manner. I don't think anybody can really say how high it could go before selling off and settling. Analysts targets of $5 or $6 have been set conservatively for a while now, but they used to be as high as $25. Oncosec has been compared to T-Vec which was acquired through a buyout by Amgen valued at 1 billion dollars. An Oncosec buyout with all shares fully diluted (I believe around 46 million shares if all warrants were to be executed) at a 1 billion dollar value would probably be around $20-$25 dollars a share.....I am taking a guess here.